Pomalyst 2 MG, 3 MG,4 MG

Ended Awarded Last action

Contract number
36C24526N0790
Awardee
Awarding agency
Obligated
$199,047

Award facts

Contract value 100% obligated
$199,047.42 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Memphis, TN 38141, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Veterans Integrated Service Network 5 issued a BPA call to Bristol-Myers Squibb Company on August 2, 2026, for POMALYST (pomalidomide) in 2 mg, 3 mg, and 4 mg strengths, with a ceiling value of $199,047.42 under the Pharmaceuticals and Drugs GSA Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with an ultimate completion date of August 31, 2026. Place of performance is Memphis, Tennessee. POMALYST is an immunomodulatory agent supplied to the VA healthcare system for eligible veteran patients.

Quick answers

Who was awarded contract 36C24526N0790?

36C24526N0790 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 5 (Veterans Health Administration) on August 2, 2026.

How much is contract 36C24526N0790 worth?

The government has obligated $199,047 on 36C24526N0790.

Is contract 36C24526N0790 an order under another contract?

Yes. 36C24526N0790 is a BPA call under 36F79724D0101-36E79726A0010, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24526N0790 competed?

The extent of competition for 36C24526N0790 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login